Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 

Biopharma

The biopharma business develops, produces and markets prescription drugs for the therapeutic areas of Neurodegenerative Diseases, Oncology, Fertility, Endocrinology, CardioMetabolic Care and General Medicine.

Neurodegenerative diseases

Our goal is to offer people living with neurodegenerative diseases, such as multiple sclerosis, therapies that contribute significantly to the quality of life and meet patients’ needs.

Oncology

In oncology, we are focusing on therapeutic options that systematically target the tumor. The key is finding the right combination. This refers both to the targets of a therapy in the disease process and to the combination possibilities with standard therapies such as radiation or chemotherapy.

Fertility

For fertility treatment, we offer hormones for every stage of the reproductive cycle – from follicular development to early pregnancy.

Endocrinology

We are committed to the treatment and research of growth hormone deficiency, the rare disorder phenylketonuria (PKU) and other metabolic disorders.

CardioMetabolic Care

We offer a comprehensive range of therapeutic options for cardiovascular diseases, diabetes and thyroid diseases, thus making a significant contribution to effective treatment of often complex symptoms.

 

Biopharma

Our biopharma business is pursuing activities in selected indications for highly specialized therapeutic areas mainly treated by specialists. The portfolio includes leading biopharmaceutical drugs that benefit patients who suffer from colorectal cancer, head and neck tumors or multiple sclerosis. In addition, we offer therapies to treat infertility, growth disorders, cardiovascular diseases, diabetes and thyroid diseases
Research and development are focused on the fields of oncology, immuno-oncology, neurodegenerative diseases, fertility, endocrinology and biosimilars.
Biopharma: Key products by therapeutic area
Therapeutic Area Key Products
Oncology
  • Erbitux® (solid tumors)
Neurodegenerative Diseases
Fertility
Endocrinology
CardioMetabolic Care
  • Glucophage® franchise (type 2 diabetes)
  • Concor® franchise (cardiovascular diseases)
  • Euthyrox® (thyroid diseases)

More in M – The Explorer Magazine:

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the USA and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Performance Materials. To reflect such fact and to avoid any misconception of the reader of the publication certain logos, terms and business descriptions of the publication have been substituted or additional descriptions have been added. Publications on this homepage, therefore, slightly deviate from the otherwise identical version of the publications provided outside the United States and Canada.
 

BIOPHARMA

www.emdserono.com

CLINICAL TRIALS

Clinical Trials
For information on clinical trials currently being conducted in the framework of our development projects, please click here.
 
  
Read more on M - The Explorer Magazine

Using nutshells for climate impact mitigation

In November 2014, cashew and coconut shells ushered in a green era at our company production site in Goa in western India. This waste material generates climate-neutral electricity.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Sweating for the rainforest

Employees of Merck KGaA, Darmstadt, Germany, have been helping to conserve the rainforest in Thailand for many years now. Recently, almost 300 volunteers planted 10,000 trees in a single day.

Read more on M - The Explorer Magazine